Dr. Agarwal's Health Care Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 24, 2025
AGARWALEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Agarwal's Health Care Limited submitted the voting results and scrutinizer's report for its 15th Annual General Meeting held on September 24, 2025 via video conferencing. All 10 resolutions were passed with the required majority, with overall participation of 96.63% (305.5 million shares out of 316.2 million). Key items included adoption of FY25 financial statements (99.9998% in favour), reappointment of Dr. Amar Agarwal, Dr. Adil Agarwal and appointment of Mr. Ankur Nand Thadani as directors, and revision in remuneration for CEO Dr. Adil Agarwal and COO Dr. Anosh Agarwal for FY26–FY28 (96.11% and 98.68% in favour respectively). The ESOP-2022 scheme and its extension to subsidiary employees were also ratified, with the extension resolution seeing the highest dissent at 5.67% against. The cost auditor and secretarial auditor appointments were also approved with near-unanimous support.
All AGM resolutions were passed, confirming shareholder support for management's agenda including executive pay revisions and the ESOP scheme. The relatively higher dissent on the CEO remuneration hike (3.89% against) and ESOP extension (5.67% against) is worth monitoring but unlikely to materially affect the stock. The strong turnout (over 96%) signals active retail and institutional engagement.